Financial Data and Key Metrics Changes - In 2025, normalized FFO per share increased by 9%, with same-store SHOP cash net operating income growing by 15%, marking the fourth consecutive year of double-digit SHOP NOI growth [7][28] - The enterprise value exceeded $50 billion, with fourth quarter annualized NOI and SHOP NOI reaching $2.5 billion and $1.3 billion, respectively [7][28] - Total shareholder returns for 2025 were 35%, significantly outperforming industry benchmarks and the S&P 500 [8] Business Line Data and Key Metrics Changes - The SHOP same-store portfolio revenue grew over 8%, driven by a 300 basis points year-over-year occupancy increase [14] - NOI for SHOP grew by 15.4% year-over-year in the fourth quarter, with margins increasing by 180 basis points to over 28% [15] - The outpatient medical and research (OMR) business saw same-store cash NOI growth of nearly 4% year-over-year in the fourth quarter [27] Market Data and Key Metrics Changes - The over 80 population is projected to grow by 28% in the next five years, creating significant demand for senior housing [8][10] - New supply of senior housing remains constrained, with only about 2,500 new units started in the fourth quarter of 2025 [9][10] - The company operates in a consumer-driven, private pay business model, which has shown resilience during adverse conditions [9] Company Strategy and Development Direction - The company aims to capitalize on the multi-year growth opportunity in senior housing through its 1, 2, 3 strategy, focusing on organic growth, value-creating investments, and cash flow generation [6][10] - The strategic vision includes enhancing financial strength and flexibility while expanding the senior housing business through aggressive investment activity [10][11] - The company plans to maintain a high single-digit growth in normalized FFO per share for 2026, with expectations of continued double-digit same-store cash NOI growth [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth potential driven by demographic trends and the aging population [8][10] - The company is well-positioned to manage the increasing demand for senior housing, with a focus on operational excellence and strong partnerships with operators [20][22] - Management acknowledged the competitive landscape but emphasized the company's unique advantages in capital deployment and operator relationships [24][25] Other Important Information - The board approved an 8% increase in the quarterly dividend, reflecting strong performance and a positive outlook [12] - The company raised $7 billion in capital during the year, enhancing its financial flexibility for future investments [30] Q&A Session Summary Question: On the Brookdale reset on the triple net side - Management indicated a reasonable assumption for the triple net business would be around 3% on average for escalators, with the January increases being an outlier [35] Question: Acquisition guidance and market competition - Management noted that the investment pipeline is active, with a mix of off-market and marketed deals, and emphasized their strong track record with repeat sellers [42][43] Question: Impact of flu season on occupancy - Management reported minimal flu impacts and highlighted improved infection control measures since the pandemic [45][46] Question: Future growth opportunities and potential dispositions - Management acknowledged ongoing pruning within the portfolio, with some underperforming senior housing assets identified for potential disposition [52] Question: Occupancy upside for acquired assets - Management indicated that many acquired assets have occupancy upside, with a focus on high-quality, stabilized properties [72][73] Question: Supply concerns in senior housing - Management expressed confidence that demand from the aging population will outpace any new supply, projecting significant growth in the over 80 demographic [96][97]

Core Viewpoint - Ventas, Inc. is positioned as a leading entity in the healthcare real estate sector, with a strong portfolio and positive growth outlook supported by strategic investments and favorable market conditions [1][2][3]. Group 1: Company Overview - Ventas, Inc. operates in the healthcare real estate sector, focusing on senior housing, medical office buildings, and research facilities [1]. - The company has a market capitalization of approximately $34.8 billion and a trading volume of 2,630,940 shares on the NYSE, indicating its significance in the healthcare REIT sector [5]. Group 2: Financial Performance - Ventas has a solid balance sheet and improved leverage, showcasing strong financial health and liquidity [3][6]. - The Zacks Consensus Estimate for Ventas' 2025 funds from operations (FFO) per share is projected to be $2.48, reflecting positive analyst sentiment [3]. Group 3: Growth Potential - The company’s strategic investments in its research portfolio and expansion of operations are driving portfolio growth and enhancing same-store cash net operating income (NOI) [4][6]. - Jefferies has set a price target of $93 for Ventas, suggesting a potential price increase of approximately 18.17% from its current price of $78.7, supported by the company's strong healthcare real estate portfolio [2][6]. Group 4: Market Position - Ventas' stock has seen an 11.9% rise over the past three months, contrasting with a 1.5% decline in the industry, indicating investor confidence in the company's performance [3][4]. - The company's diverse assets are well-positioned to benefit from rising healthcare spending and an aging population, enhancing its attractiveness to investors [2].

Financial Data and Key Metrics Changes - The company reported normalized FFO of 84¢ per share, representing nearly 8% year-over-year growth [28] - Total same store cash NOI grew by 7%, led by SHOP increasing approximately 14% [29] - The company expects 7% normalized FFO per share growth for 2025 [6][11] Business Line Data and Key Metrics Changes - Senior Housing Operating Portfolio (SHOP) delivered 84¢ of normalized FFO per share in Q1, an increase of approximately 8% [7] - SHOP's same store cash NOI growth was 13.6%, with revenue growth of 7.4% driven by occupancy and rate increases [15] - Outpatient medical and research business reported same store cash NOI growth of 1.3% year-over-year [29] Market Data and Key Metrics Changes - The 80+ population is experiencing its highest growth, with an increase of about half a million people this year and 900,000 annually between 2027 and 2030 [8] - The number of new senior housing units started in Q1 2025 was the lowest on record at only 1,287 units [8] - The company is positioned in markets with over a thousand basis points of expected net absorption in the coming years [9] Company Strategy and Development Direction - The company is focused on delivering superior multiyear growth through internal and external expansion in senior housing [5] - The investment strategy has been increased from $1 billion to $1.5 billion for the year, reflecting a growing pipeline of opportunities [31][26] - The company aims to enhance its portfolio composition through acquisitions, dispositions, and operational improvements [19] Management's Comments on Operating Environment and Future Outlook - Management acknowledges a high degree of macroeconomic uncertainty but believes senior housing remains a top asset class within real estate [87] - The company expects strong demand and occupancy growth, particularly during the key selling season [88] - Management is optimistic about the extended multiyear NOI growth opportunity in senior housing due to favorable demand and supply dynamics [11][88] Other Important Information - The company has improved its credit profile, with a net debt to EBITDA of 5.7 times, representing a 30 basis point improvement from the previous year [32] - The liquidity position is robust, with available liquidity of $3.6 billion as of April 2025 [33] - The company has completed over 250 community redevelopment projects in the past two and a half years [21] Q&A Session Summary Question: Can you provide more details on the dynamics of occupancy and margin expansion? - Management indicated that reaching higher occupancy levels leads to significant margin expansion, with around 50% incremental margin from 80% to 90% occupancy [39] Question: How is the Canadian portfolio performing at high occupancy? - The Canadian portfolio continues to deliver strong NOI growth even at high occupancy levels, demonstrating that occupancy is not the only driver of growth [42] Question: What is the impact of the recent investments on cost per bed? - The cost per bed has increased due to acquiring newer communities in better markets, but the company is still buying below replacement costs [56][60] Question: How are the Brookdale assets expected to perform during the transition? - The Brookdale communities transitioning to new operators are outperforming those remaining in the lease model, and management is optimistic about their future performance [66][71] Question: What are the expectations for pricing power in the upcoming months? - Management expects pricing power to remain strong, with good rent increases anticipated during the key selling season [80] Question: How does the company view the potential changes in NIH funding? - Management believes that any potential changes in NIH funding would have a manageable impact on the research budget due to the strong financial position of their university tenants [113]